Microbiosci

Microbiosci is the microbiology-focused business unit of Creative Biogene that provides microbial strain engineering, fermentation, cell banking, recombinant protein production, and related development and manufacturing services. The group appears to operate primarily as a biotech services and microbial CDMO/CRO platform rather than as a therapeutics developer with a disclosed proprietary clinical pipeline. Its capabilities span microbial strain selection and optimization, microbial cell line generation, GMP-compliant cell banking, fermentation scale-up, downstream purification, and production support for recombinant proteins, plasmid DNA, vaccines, enzymes, and related biologic materials. Microbiosci markets support for therapeutic, diagnostic, research, and industrial applications, including pilot and early clinical supply services. Based on available public information, it is best characterized as an active life-science services platform within Creative Biogene.